{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T22:40:22Z","timestamp":1772923222293,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T00:00:00Z","timestamp":1392595200000},"content-version":"vor","delay-in-days":1357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oarsijournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Osteoarthritis and Cartilage"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.joca.2010.01.018","type":"journal-article","created":{"date-parts":[[2010,4,17]],"date-time":"2010-04-17T08:04:57Z","timestamp":1271491497000},"page":"S32-S40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"S1","title":["Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study"],"prefix":"10.1016","volume":"18","author":[{"given":"I.","family":"M\u00f6ller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Monfort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Benito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Cuevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Perna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Dom\u00e9nech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Montell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Verg\u00e9s","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.joca.2010.01.018_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.7326\/0003-4819-133-8-200010170-00016","article-title":"Osteoarthritis: new insights. Part 1: the disease and its risk factors","volume":"133","author":"Felson","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.joca.2010.01.018_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.rdc.2008.05.007","article-title":"Epidemiology of osteoarthritis","volume":"34","author":"Zhang","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.joca.2010.01.018_bib3","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1185\/030079908X297231","article-title":"Chondroitin sulphate for symptomatic osteoarthritis: critical appraisal of meta-analyses","volume":"24","author":"Monfort","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"Suppl A","key":"10.1016\/j.joca.2010.01.018_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1063-4584(98)80004-6","article-title":"Chondroitin sulfate and joint disease","volume":"6","author":"Hardingham","year":"1998","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2010.01.018_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.joca.2004.01.004","article-title":"Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo","volume":"12","author":"Uebelhart","year":"2004","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2010.01.018_bib6","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/art.24255","article-title":"Long-term effects of chondroitins 4 and 6 sulfate on knee osteoarthritis: the study on osteoarthritis progression prevention, a two-year, randomized, double-blind, placebo-controlled trial","volume":"60","author":"Kahan","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2010.01.018_bib7","first-page":"205","article-title":"A meta-analysis of chondroitin sulfate in the treatment of osteoarthritis","volume":"27","author":"Leeb","year":"2000","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joca.2010.01.018_bib8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa052771","article-title":"Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis","volume":"354","author":"Clegg","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.joca.2010.01.018_bib9","first-page":"1385","article-title":"Comparison of the anti-inflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis","volume":"23","author":"Morreale","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joca.2010.01.018_bib10","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1001\/archinte.163.13.1514","article-title":"Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis","volume":"163","author":"Richy","year":"2003","journal-title":"Arch Intern Med"},{"issue":"Suppl A","key":"10.1016\/j.joca.2010.01.018_bib11","first-page":"S35","article-title":"The efficacy of chondroitin sulfate in the treatment of knee osteoarthritis: a metaanalysis","volume":"7","author":"Sarmiento","year":"1999","journal-title":"Osteoarthritis Cartilage"},{"issue":"Suppl A","key":"10.1016\/j.joca.2010.01.018_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S1063-4584(98)80011-3","article-title":"Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study","volume":"6","author":"Uebelhart","year":"1998","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2010.01.018_bib13","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10067-002-8290-7","article-title":"Systems to assess the progression of finger joint osteoarthritis and the effects of disease modifying osteoarthritis drugs","volume":"21","author":"Verbruggen","year":"2002","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.joca.2010.01.018_bib14","first-page":"29","article-title":"Chondroitin sulfate in erosive osteoarthritis of the hands","volume":"24","author":"Rovetta","year":"2002","journal-title":"Int J Tissue React"},{"key":"10.1016\/j.joca.2010.01.018_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1742-7843.2007.00158.x","article-title":"Chondroitin sulfate inhibits the nuclear translocation of Nuclear Factor-kappaB in interleukin-1beta-stimulated chondrocytes","volume":"102","author":"Jomphe","year":"2008","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"Suppl 3","key":"10.1016\/j.joca.2010.01.018_bib16","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.joca.2008.06.008","article-title":"Anti-inflammatory activity of chondroitin sulfate","volume":"16","author":"Iovu","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2010.01.018_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/ard.2006.068882","article-title":"Biochemical basis of the effect of chrondroitin sulfate on osteoarthritis articular disease","volume":"67","author":"Monfort","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2010.01.018_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0898-6568(02)00080-3","article-title":"Involvement of NF-kappaB signalling in skin physiology and disease","volume":"15","author":"Bell","year":"2003","journal-title":"Cell Signal"},{"key":"10.1016\/j.joca.2010.01.018_bib19","first-page":"739","article-title":"Clinical and histopathological improvement of psoriasis in patients with osteoarthritis treated with chondroitin sulfate: report of 3 cases","volume":"123","author":"Verg\u00e9s","year":"2004","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.joca.2010.01.018_bib20","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5070\/D32ZH8X3VF","article-title":"Clinical and histopathological improvement of psoriasis with oral chondroitin sulfate: a serendipitous finding","volume":"11","author":"Verg\u00e9s","year":"2005","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.joca.2010.01.018_bib21","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1002\/1529-0131(200009)43:9<1905::AID-ANR1>3.0.CO;2-P","article-title":"Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update","volume":"43","author":"American College of Rheumatology Subcommittee on Osteoarthritis Guidelines","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.joca.2010.01.018_bib22","first-page":"768","article-title":"Measurement of pain","volume":"9","author":"Huskisson","year":"1982","journal-title":"J Rheumatol"},{"key":"10.1016\/j.joca.2010.01.018_bib23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","article-title":"Radiological assessment of osteo-arthrosis","volume":"16","author":"Kellgren","year":"1957","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2010.01.018_bib24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis-oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1016\/j.joca.2010.01.018_bib25","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI) \u2013 a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.joca.2010.01.018_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/03009748709102182","article-title":"Indexes of severity for osteoarthritis of the hip and knee. Validation\u2013value in comparison with other assessment tests","volume":"65","author":"Lequesne","year":"1987","journal-title":"Scand J Rheumatol Suppl"},{"key":"10.1016\/j.joca.2010.01.018_bib27","first-page":"173","article-title":"Chondroitin sulfate in osteoarthritis of the knee: a prospective, double blind, placebo controlled multicenter clinical study","volume":"28","author":"Mazi\u00e8res","year":"2001","journal-title":"J\u00a0Rheumatol"},{"issue":"Suppl A","key":"10.1016\/j.joca.2010.01.018_bib28","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1063-4584(98)80009-5","article-title":"Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis","volume":"6","author":"Bucsi","year":"1998","journal-title":"Osteoarthritis Cartilage"},{"issue":"Suppl A","key":"10.1016\/j.joca.2010.01.018_bib29","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1063-4584(98)80008-3","article-title":"Efficacy and tolerability of chondroitin sulfate 1200mg\/day vs chondroitin sulfate 3\u00d7400mg\/day vs placebo","volume":"6","author":"Bourgeois","year":"1998","journal-title":"Osteoarthritis Cartilage"},{"issue":"Suppl 3","key":"10.1016\/j.joca.2010.01.018_bib30","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.joca.2008.06.006","article-title":"Clinical review of chondroitin sulfate in osteoarthritis","volume":"16","author":"Uebelhart","year":"2008","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.joca.2010.01.018_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/ard.2003.010769","article-title":"Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study","volume":"63","author":"Picavet","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.joca.2010.01.018_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1067\/S0190-9622(03)01479-8","article-title":"Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice","volume":"49","author":"Pettey","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.joca.2010.01.018_bib33","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.bcp.2007.10.027","article-title":"Anti-inflammatory interventions of NF-kappaB signaling: potential applications and risks","volume":"75","author":"Uwe","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.joca.2010.01.018_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1600-0560.2007.00841.x","article-title":"Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study","volume":"35","author":"Abdou","year":"2008","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.joca.2010.01.018_bib35","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.clindermatol.2003.08.015","article-title":"Changing paradigms in dermatology: tumor necrosis factor alpha (TNF-alpha) blockade in psoriasis and psoriatic arthritis","volume":"21","author":"Victor","year":"2003","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.joca.2010.01.018_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.21300","article-title":"Transcriptional responses of human epidermal keratinocytes to cytokine interleukin-1","volume":"214","author":"Yano","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.joca.2010.01.018_bib37","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/j.0022-202X.2005.23735.x","article-title":"Differential expression of phosphorylated NF-kappaB\/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept","volume":"124","author":"Lizzul","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.joca.2010.01.018_bib38","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/sj.bjp.0707394","article-title":"Antipsoriatic effects of avarol-3\u2032-thiosalicylate are mediated by inhibition of TNF-alpha generation and NF-kappaB activation in mouse skin","volume":"152","author":"Amigo","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.joca.2010.01.018_bib39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.ejphar.2008.02.038","article-title":"Dimethyl fumarate, a small molecule drug for psoriasis, inhibits Nuclear Factor-kappaB and reduces myocardial infarct size in rats","volume":"586","author":"Meili-Butz","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.joca.2010.01.018_bib40","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2133.2005.06779.x","article-title":"FK506 inhibits tumour necrosis factor-alpha secretion in human keratinocytes via regulation of Nuclear Factor-kappaB","volume":"153","author":"Lan","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.joca.2010.01.018_bib41","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-4362.1997.00176.x","article-title":"Coal tar therapy in palmoplantar psoriasis: old wine in an old bottle?","volume":"36","author":"Bhushan","year":"1997","journal-title":"Int J Dermatol"},{"issue":"4 Suppl 1","key":"10.1016\/j.joca.2010.01.018_bib42","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1016\/j.jaad.2005.10.032","article-title":"Efalizumab retreatment in patients with moderate to severe chronic plaque psoriasis","volume":"54","author":"Papp","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.joca.2010.01.018_bib43","first-page":"1116","article-title":"Comedication related to comorbidities: a study in 1203 hospitalized patients with severe psoriasis","volume":"159","author":"Gerdes","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.joca.2010.01.018_bib44","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1080\/00015550510032823","article-title":"Drug exposure and psoriasis vulgaris: case\u2013control and case-crossover studies","volume":"85","author":"Cohen","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.joca.2010.01.018_bib45","first-page":"269","article-title":"Diagnosis of drug-induced psoriasis","volume":"11","author":"Abel","year":"1992","journal-title":"Semin Dermatol"},{"key":"10.1016\/j.joca.2010.01.018_bib46","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/archderm.139.9.1223","article-title":"Psoriasis associated with rofecoxib","volume":"139","author":"Clark","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.joca.2010.01.018_bib47","first-page":"45","article-title":"Exacerbation of psoriasis by ibuprofen","volume":"38","author":"Ben-Chetrit","year":"1986","journal-title":"Cutis"},{"key":"10.1016\/j.joca.2010.01.018_bib48","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2133.1987.tb07364.x","article-title":"Exacerbation of psoriasis by indomethacin","volume":"117","author":"Powles","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.joca.2010.01.018_bib49","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1346-8138.1981.tb02551.x","article-title":"Exacerbation of psoriasis induced by indomethacin","volume":"8","author":"Katayama","year":"1981","journal-title":"J Dermatol"},{"key":"10.1016\/j.joca.2010.01.018_bib50","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2165\/00128071-200001030-00003","article-title":"Drug-induced psoriasis. Recognition and management","volume":"1","author":"Tsankov","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.joca.2010.01.018_bib51","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2133.1983.tb04000.x","article-title":"Generalized pustular psoriasis precipitated by phenylbutazone and oxyphenbutazone","volume":"109","author":"Reshad","year":"1983","journal-title":"Br J Dermatol"}],"container-title":["Osteoarthritis and Cartilage"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458410000907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1063458410000907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:22:27Z","timestamp":1761016947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1063458410000907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":51,"alternative-id":["S1063458410000907"],"URL":"https:\/\/doi.org\/10.1016\/j.joca.2010.01.018","relation":{},"ISSN":["1063-4584"],"issn-type":[{"value":"1063-4584","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of chondroitin sulphate in patients with concomitant knee osteoarthritis and psoriasis: a randomized, double-blind, placebo-controlled study","name":"articletitle","label":"Article Title"},{"value":"Osteoarthritis and Cartilage","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joca.2010.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}